Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma
Not Applicable
- Conditions
- Renal cell carcinoma
- Registration Number
- JPRN-jRCT2031210003
- Lead Sponsor
- Contact for Clinical Trial Information
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 388
Inclusion Criteria
Patients with radically unresectable or metastatic renal cell carcinoma who do not meet the following exclusion criterion are eligible.
Exclusion Criteria
A patient who has a history of hypersensitivity to any component of cabozantinib
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method